9 results
Differential Diagnosis and Evaluation of Hyponatremia:
1) Identification of onset (acute vs. chronic)
2) Presence of symptoms (HA,
and Evaluation ... Identification of onset (acute ... , liver, renal disease ... #Differential #Algorithm ... #Ddxof
Posterior Reversible Encephalopathy Syndrome (PRES) - Diagnosis
Clinical Features:
 • Altered mental status (Either lethargy, confusion, or
Encephalopathy Syndrome (PRES ... Immunomodulatory meds ... • Autoimmune disease ... EricsMedicalLectures/ #PRES ... #Neurology
Hyponatremia - Differential Diagnosis Algorithm
Hypovolemic - Give volume
Hypervolemic (Edematous) - Look for and treat underlying cause
Stress, Nausea, Pulmonary ... Diseases, CNS Disease ... , Meds (Opiates, ... #Algorithm #diagnosis ... #nephrology #sodium
Guide to Acute Kidney Injury (AKI)

What to ask/look for: 
 - HPI, PMH, full ROS
Guide to Acute Kidney ... ATN - 45% - Pre-renal ... disease — 21% ... AcuteKidneyInjury #AKI #Nephrology ... #Diagnosis #Algorithm
Algorithm for the Evaluation of Kawasaki and Incomplete Kawasaki Disease:
Diagnosis
* Fever >5d
* Criteria (4/5)
  -
Algorithm for the ... Evaluation of Kawasaki ... : Diagnosis * ... #Peds #Pediatrics ... #Ddxof
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Shock, Autoimmune disease ... Neurological symptoms: Acute ... syndrome, ADEM, Acute ... Seizures: Treat with AEDs ... #management #neurology
Evaluation of suspected incomplete Kawasaki Disease

1. AHA consensus recommendations
2. Infants ≤6 months old on day ≥7
Evaluation of suspected ... incomplete Kawasaki Disease ... purposes of this algorithm ... other suggestive features ... #Diagnosis #Peds
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk Evaluation ... Major Pre-Op ... murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... stratification #diagnosis
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... to acute myeloid ... median age at diagnosis ... cardiovascular or pulmonary